Developing Patient-Centered “Primary Care Pharmacists and Pharmacies”
First written in FY2017-Q1. 19 of 29 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2025: 1 of 10 companies on the "Worse" side.
2 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The company implemented initiatives to increase sales per store and focused on expanding community-coordination pharmacies and pharmacies linked to specialized medical institutions, as well as addressing home healthcare needs.」
The company continues to build pharmacies chosen by local communities by increasing sales per store, expanding community-coordination pharmacies and pharmacies linked to specialized medical institutions, and addressing home healthcare needs. - FY2025RestatedAnnual report
「The Group will continue to prioritize safety above all else, further enhance the functions of family pharmacists and pharmacies trusted by local communities, seek to improve customer satisfaction, and promote the development of pharmacies that are resilient to competition.」
The company continues to pursue initiatives in its dispensing pharmacy business to enhance the functions of family pharmacists and pharmacies, improve customer satisfaction, and build pharmacies that can compete effectively. - FY2024-Q3RestatedAnnual report
「In the dispensing pharmacy business, the Group has worked to expand sales per store by developing store formats that make it easier for patients to visit, while also expanding community-coordination pharmacies. It has also expanded initiatives led by its subsidiary, Healthy Pharmacy Co., Ltd., to address the needs of patients who have difficulty visiting pharmacies. Through these activities, the Group is improving satisfaction for each individual patient and building pharmacies chosen by local residents.」
The Group continues to strengthen sales per store, develop store formats that are easy to visit, expand community-coordination pharmacies, and address home-care needs primarily through Healthy Pharmacy Co., Ltd. - FY2024-Q2RestatedAnnual report
「In the dispensing pharmacy business, the Group has worked to expand sales per store by developing store formats that make it easier for patients to visit, while also expanding community-coordination pharmacies. It has also expanded initiatives led by its subsidiary, Healthy Pharmacy Co., Ltd., to address the needs of patients who have difficulty visiting pharmacies. Through these activities, the Group is improving satisfaction for each individual patient and building pharmacies chosen by local residents.」
The Group continues to strengthen sales per store, develop store formats that are easy to visit, expand community-coordination pharmacies, and address home-care needs primarily through Healthy Pharmacy Co., Ltd. - FY2024-Q1ReframedAnnual report
「In the dispensing pharmacy business, the Group is working to expand sales per store by developing store formats that make it easier for patients to visit, while also expanding community-coordination pharmacies.」
In its efforts to build pharmacies chosen by local residents, the Group explicitly addresses increasing sales per store and developing store formats that are easy to visit, in addition to its existing response to function-based pharmacies and the home-care market. - FY2023RestatedAnnual report
「The Group will continue to prioritize safety above all else, further enhance the functions of family pharmacists and pharmacies trusted by local communities, seek to improve customer satisfaction, and promote the development of pharmacies that are resilient to competition.」
The Group continues to pursue improved functions for family pharmacists and pharmacies, higher customer satisfaction, and the development of pharmacies that are resilient to competition as strategies for its dispensing pharmacy business. - FY2023-Q3RestatedAnnual report
「The Group focused on quality-oriented new store openings and worked to renovate and strengthen existing stores while expanding community-coordination pharmacies and pharmacies cooperating with specialized medical institutions.」
The Group continues to build pharmacies chosen by local patients through quality-focused store openings, renovation and strengthening of existing stores, and expansion of community-coordination pharmacies and pharmacies cooperating with specialized medical institutions. - FY2023-Q2AdvancedAnnual report
「In July of the same year, the Group opened Flower Pharmacy Nabari-Higashi, proceeded with quality-focused new store openings, and worked to renovate and strengthen existing stores while focusing on expanding community-coordination pharmacies and pharmacies cooperating with specialized medical institutions. It also steadily advanced initiatives in the home-care market to address the needs of patients who have difficulty visiting pharmacies.」
The Group opened Flower Pharmacy Nabari-Higashi in July 2022 and is advancing quality-focused store openings, renovation and strengthening of existing stores, expansion of community-coordination pharmacies and pharmacies cooperating with specialized medical institutions, and initiatives in the home-care market. - FY2023-Q1ReframedAnnual report
「The Group is selectively opening high-quality stores while renovating and strengthening core stores and working to expand community-coordination pharmacies and pharmacies cooperating with specialized medical institutions. It is also focusing on the home-care market to address the needs of patients who have difficulty visiting pharmacies, thereby fulfilling pharmacists’ mission and building pharmacies chosen by local residents.」
The Group has expanded its longstanding efforts to build family pharmacies into specific measures, including selective openings of high-quality stores, renovation and strengthening of core stores, expansion of community-coordination pharmacies and pharmacies cooperating with specialized medical institutions, and a focus on the home-care market. - FY2022-Q3RestatedAnnual report
「In the dispensing pharmacy business, the Group has focused on community-based initiatives, including activities aimed at qualifying as health-support pharmacies, to help support the community-based integrated care system. Through these activities, the Group will continue to build pharmacies chosen by local residents while maintaining close cooperation with hospitals, clinics and care facilities.」
The Group continues to build pharmacies chosen by local residents through participation in the community-based integrated care system, activities aimed at qualifying as health-support pharmacies, and cooperation with healthcare and care-service providers. - FY2022-Q2AdvancedAnnual report
「In August 2021, Flower Pharmacy Hattori in Iga, Mie Prefecture, became eligible to operate as a health-support pharmacy. Also in August, Hisai Center Pharmacy in Tsu, Mie Prefecture, was accredited as a community-coordination pharmacy. Through these initiatives, the Group is helping to support the community-based integrated care system and building pharmacies chosen by local residents through close cooperation with hospitals, clinics, care facilities and other pharmacies.」
The Group describes concrete progress, including Flower Pharmacy Hattori’s eligibility as a health-support pharmacy and Hisai Center Pharmacy’s accreditation as a community-coordination pharmacy, and is developing pharmacies chosen by local residents through cooperation with healthcare and care-service providers. - FY2022-Q1ReframedAnnual report
「In the dispensing pharmacy business, the Group faces major changes, including the introduction from August 2021 of a function-based pharmacy accreditation system under the revised Pharmaceuticals and Medical Devices Act (the Act Partially Amending the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices and Other Acts), enabling patients to choose pharmacies suited to their needs. In response, the Group is developing an environment that enables patients to take medication appropriately and with confidence, strengthening information sharing and cooperation with medical institutions, and building pharmacies chosen by patients.」
The Group has incorporated into its longstanding efforts centered on family pharmacies and the pharmacy vision a function-based accreditation system under the revised Pharmaceuticals and Medical Devices Act, improvements to the medication environment, stronger information sharing and cooperation with medical institutions, and the development of pharmacies chosen by patients. - FY2021-Q3ReframedAnnual report
「The Act Partially Amending the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices and Other Acts (the revised Pharmaceuticals and Medical Devices Act) introduced a pharmacy accreditation system, among other measures. From September 2020, follow-up during the medication period also became mandatory where necessary, resulting in major changes to the roles expected of pharmacies and pharmacists. The Group prioritizes safety above all else and is working to build pharmacies trusted by local communities, where pharmacists fulfill their expected roles through family pharmacy services, home-care services and other activities.」
The Group has incorporated changes in roles under the revised Pharmaceuticals and Medical Devices Act, including mandatory follow-up during the medication period from September 2020, into its previous efforts related to the “Patient-Centered Pharmacy Vision” and family pharmacies. - FY2021-Q2RestatedAnnual report
「Following the enactment in November 2019 of the Act Partially Amending the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices and Other Acts (the revised Pharmaceuticals and Medical Devices Act), which introduced a pharmacy accreditation system and strengthened medication guidance, among other measures, the environment surrounding pharmacies and pharmacists has changed significantly. The Group prioritizes safety above all else and is working to build pharmacies trusted by local communities, where pharmacists fulfill their expected roles through family pharmacy services, home-care services and other activities.」
Against the backdrop of the pharmacy accreditation system and strengthened medication guidance under the revised Pharmaceuticals and Medical Devices Act, the Group continues to build pharmacies through family pharmacy services, home-care services, and pharmacists fulfilling their expected roles. - FY2021-Q1ReframedAnnual report
「In the dispensing pharmacy industry, the environment surrounding pharmacies and pharmacists has changed significantly following the enactment in November 2019 of the Act Partially Amending the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices and Other Acts (the revised Pharmaceuticals and Medical Devices Act), which introduced a pharmacy accreditation system and strengthened medication guidance, among other measures. The Group prioritizes safety above all else and is working to build pharmacies trusted by local communities, where pharmacists fulfill their expected roles.」
The Group has incorporated the new institutional environment created by the revised Pharmaceuticals and Medical Devices Act, including the pharmacy accreditation system, strengthened medication guidance, and changes in pharmacists’ roles, into its previous descriptions of the “Patient-Centered Pharmacy Vision” and efforts to build family pharmacies. - FY2020-Q3RestatedAnnual report
「In the dispensing pharmacy industry, as indicated in the Ministry of Health, Labour and Welfare’s “Patient-Centered Pharmacy Vision,” pharmacists’ work is shifting from product-focused services to patient-focused services.」
The Group refers to changes in pharmacists’ roles against the backdrop of the “Patient-Centered Pharmacy Vision” and continues to pursue the development of pharmacies trusted by local communities. - FY2020-Q2RestatedAnnual report
「In this business environment, the Group is working to secure earnings by further enhancing the functions of family pharmacists and family pharmacies and further promoting the acceptance of prescriptions as pharmacies trusted by local communities, among other measures.」
The Group continues to enhance the functions of family pharmacists and family pharmacies and promote prescription acceptance. - FY2020-Q1RestatedAnnual report
「In this business environment, the Group is working to secure earnings by further enhancing the functions of family pharmacists and family pharmacies trusted by local communities and further promoting the acceptance of prescriptions, among other measures.」
The Group continues to enhance the functions of family pharmacists and family pharmacies trusted by local communities and promote prescription acceptance. - FY2019RestatedAnnual report
「The Group will continue to prioritize safety above all else, further enhance the functions of family pharmacists and pharmacies trusted by local communities, seek to improve customer satisfaction, and promote the development of pharmacies that are resilient to competition.」
The Group continues to enhance the functions of family pharmacists and pharmacies, improve customer satisfaction, and build pharmacies that are resilient to competition. - FY2019-Q3RaisedAnnual report
「In this business environment, the Group is working to secure earnings by further enhancing the functions of family pharmacists and pharmacies trusted by local communities and further promoting the acceptance of prescriptions, among other measures.」
The Group has strengthened its description of its longstanding efforts to build family pharmacies by emphasizing further enhancement of their functions and the promotion of prescription acceptance. - FY2019-Q2RestatedAnnual report
「Against this business backdrop, in line with its existing policy of making safety the top priority, the Group is pursuing initiatives to build “family pharmacies” trusted by local communities.」
Against the backdrop of the development of the community-based integrated care system and changes in the roles of pharmacies and pharmacists, the Group continues to build family pharmacies trusted by local communities. - FY2019-Q1RestatedAnnual report
「In the dispensing pharmacy business, the roles expected of pharmacies and pharmacists have changed significantly as the community-based integrated care system develops, while the revision has made the environment surrounding pharmacy chains and large pharmacies located near medical institutions increasingly challenging. In line with its longstanding policy, the Group continues to prioritize safety above all else and advance initiatives aimed at building family pharmacies trusted by local communities.」
The Group continues to build family pharmacies trusted by local communities while addressing changes in the roles of pharmacies and pharmacists accompanying the development of the community-based integrated care system. - FY2018RestatedAnnual report
「The Group continues to prioritize safety above all else in line with its longstanding policy and, based on these measures, is advancing initiatives aimed at building family pharmacies trusted by local communities. In addition, by providing healthcare services from the patient’s perspective while prioritizing safety above all else, the Group will seek to improve customer satisfaction and promote the development of pharmacies that are resilient to competition.」
The Group continues to build family pharmacies within the framework of earning the trust of local communities, providing healthcare services from the patient’s perspective, and improving customer satisfaction. - FY2018-Q3RestatedAnnual report
「In its core dispensing pharmacy business, the Group is advancing initiatives aimed at realizing the “Patient-Centered Pharmacy Vision.”」
The Group continues initiatives aimed at realizing the “Patient-Centered Pharmacy Vision.” - FY2018-Q2RestatedAnnual report
「In its core dispensing pharmacy business, the Group is advancing initiatives aimed at realizing the “Patient-Centered Pharmacy Vision.”」
The Group continues initiatives aimed at realizing the “Patient-Centered Pharmacy Vision.” - FY2018-Q1RestatedAnnual report
「The April 2016 revision of dispensing fees incorporated measures aimed at realizing the “Patient-Centered Pharmacy Vision,” resulting in major changes to the roles expected of pharmacies and pharmacists.」
The Group continues to describe its longstanding efforts to build family pharmacies within the framework of the “Patient-Centered Pharmacy Vision” and changes in the roles of pharmacies and pharmacists. - FY2017-Q3ReframedAnnual report
「This revision incorporated measures aimed at realizing the “Patient-Centered Pharmacy Vision,” resulting in major changes to the roles expected of pharmacies and pharmacists.」
The Group describes the themes related to its longstanding efforts to build family pharmacies within the framework of realizing the “Patient-Centered Pharmacy Vision” and changes in the roles of pharmacies and pharmacists. - FY2017-Q2RestatedAnnual report
「The April 2016 revision of dispensing fees introduced, among other measures, an assessment of family pharmacists and pharmacies, requiring responses to increasingly diverse needs. The Group is providing staff training and developing its stores with the aim of creating family pharmacists and pharmacies from the patient’s perspective.」
Against the backdrop of the revision of dispensing fees, the Group continues initiatives aimed at creating family pharmacists and pharmacies from the patient’s perspective. - FY2017-Q1First statedAnnual report
「The April 2016 revision of dispensing fees introduced, among other measures, an assessment of family pharmacists and pharmacies, requiring responses to increasingly diverse needs. The Group is providing staff training and developing its stores with the aim of creating family pharmacists and pharmacies from the patient’s perspective.」
Following the revision of dispensing fees, the Group identifies staff training and store development as means of responding to diverse patient needs.